Search

Author/Creator Lin, Aimee Bence

1. Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. Issue 10 (November 2015)

Authors:
Doi, Toshihiko; Yoshino, Takayuki; Shitara, Kohei; Matsubara, Nobuaki; Fuse, Nozomu; Naito, Yoichi; Uenaka, Kazunori; Nakamura, Takashi; Hynes, Scott M.; Lin, Aimee Bence
Journal:
Anti-cancer drugs
Issue:
Volume 26:Issue 10(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors. Issue 10 (November 2015)

Authors:
Doi, Toshihiko; Yoshino, Takayuki; Shitara, Kohei; Matsubara, Nobuaki; Fuse, Nozomu; Naito, Yoichi; Uenaka, Kazunori; Nakamura, Takashi; Hynes, Scott M.; Lin, Aimee Bence
Journal:
Anti-cancer drugs
Issue:
Volume 26:Issue 10(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom. (21st June 2018)

Authors:
La, Elizabeth M.; Smyth, Emily Nash; Talbird, Sandra E.; Li, Li; Kaye, James A.; Lin, Aimee Bence; Bowman, Lee
Journal:
European journal of cancer care
Issue:
Volume 27:Number 5(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search